Cargando…
Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack
Therapeutic vaccination regimens inducing clinically effective tumor-specific CD8(+) T lymphocyte (CTL) responses are an unmet medical need. We engineer two distantly related arenaviruses, Pichinde virus and lymphocytic choriomeningitis virus, for therapeutic cancer vaccination. In mice, life-replic...
Autores principales: | Bonilla, Weldy V., Kirchhammer, Nicole, Marx, Anna-Friederike, Kallert, Sandra M., Krzyzaniak, Magdalena A., Lu, Min, Darbre, Stéphanie, Schmidt, Sarah, Raguz, Josipa, Berka, Ursula, Vincenti, Ilena, Pauzuolis, Mindaugas, Kerber, Romy, Hoepner, Sabine, Günther, Stephan, Magnus, Carsten, Merkler, Doron, Orlinger, Klaus K., Zippelius, Alfred, Pinschewer, Daniel D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974551/ https://www.ncbi.nlm.nih.gov/pubmed/33763654 http://dx.doi.org/10.1016/j.xcrm.2021.100209 |
Ejemplares similares
-
Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform
por: Lauterbach, Henning, et al.
Publicado: (2021) -
The Janus Kinase Inhibitor Ruxolitinib Prevents Terminal Shock in a Mouse Model of Arenavirus Hemorrhagic Fever
por: Sahin, Mehmet, et al.
Publicado: (2021) -
Envelope Exchange for the Generation of Live-Attenuated Arenavirus Vaccines
por: Bergthaler, Andreas, et al.
Publicado: (2006) -
Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy
por: Kallert, Sandra M., et al.
Publicado: (2017) -
Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse?
por: Steinbach, Karin, et al.
Publicado: (2018)